Neoantigen immunotherapy: a novel treatment for bladder cancer
Bladder cancer is currently the most common malignant tumor of the urinary system. The traditional treatment methods for bladder cancer are mainly surgery, chemotherapy, radiotherapy, and targeted therapy; however, these treatment methods do not improve the clinical prognosis of patients with advanc...
Saved in:
Main Authors: | Ruiyang Lv, Zhenzhu Liu, Maoxin Lv, Yuze Song, Junlin Wang, Huizhi Mu, Yu Zhang, Xuejian Wang |
---|---|
Format: | Article |
Language: | English |
Published: |
Open Exploration Publishing Inc.
2025-01-01
|
Series: | Exploration of Targeted Anti-tumor Therapy |
Subjects: | |
Online Access: | https://www.explorationpub.com/uploads/Article/A1002288/1002288.pdf |
Tags: |
Add Tag
No Tags, Be the first to tag this record!
|
Similar Items
-
Unveiling immunogenic characteristics and neoantigens in endometrial cancer with POLE hotspot mutations for improved immunotherapy
by: Jian Huang, et al.
Published: (2025-01-01) -
Immunotherapies to Nano-Immunotherapies: Advances in Immune Targeting in Bladder Cancer
by: Beatriz Ramos, et al.
Published: (2025-02-01) -
Identification of neoantigens derived from alternative splicing and RNA modification
by: Jiyeon Park, et al.
Published: (2019-08-01) -
Comparison of treatments for preventing lower urinary tract symptoms after BCG immunotherapy of bladder tumors : a systematic review and network meta-analysis
by: Zihao Chen, et al.
Published: (2025-01-01) -
Ddx21 mutant peptide is an effective neoantigen in prophylactic lung cancer vaccines and activates long-term anti-tumor immunity
by: Zhe Zhang, et al.
Published: (2025-02-01)